According to a new study, acetylcholinesterase inhibitors commonly used to help treat Alzheimer's disease appear to help smokers reduce cigarette consumption.
Finding it difficult to quit smoking? Your genes may be to blame. Researchers discover genetic mutations play a key role in nicotine relapse.
Researchers have pinpointed why quitting smoking is more difficult for people who are depressed.
Quitting smoking can help reduce depression and anxiety within weeks, a new study reports.
It is widely known that smoking inhibits appetite, but what is not known, is what triggers this process in the...
Pleasant olfactory cues hold promise for helping to curb the urge to smoke in those who are quitting. Exposure to olfactory cues reduced symptoms of cravings, with effects lasting up to five minutes following exposure.
Researchers report a person's ability to quit smoking could be influenced by a neural network associated with inhibiting automated behavior.
Using the Big Five model of personality traits, researchers found smokers were more likely to experience an increase in neuroticism over time. Quitting smoking did not have an impact on altering the negative personality traits.
A new study reports viewing graphic anti-smoking images on cigarette packs triggers brain activity in areas associated with emotion, memory and decision making.
Researchers report allowing smokers to dictate their nicotine intake while trying to quit makes them more likely to succeed. Results suggest most smokers who use nicotine replacement medications can tolerate doses that are four times higher than normally recommended.
Between 60-90% of people with schizophrenia smoke, compared to between 15-24% of the general population. A new study found 40% of those with schizophrenia stopped smoking traditional cigarettes after 12 weeks of switching to e-cigarettes. Researchers also reported a significant number of participants sustained their reduction in smoking or completely stopped smoking at the end of the 12-week study.
Weill Cornell researchers develop novel antibody vaccine that blocks addictive nicotine chemicals from reaching the brain. Researchers at Weill Cornell...
